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osting by EAbstract In the present study, an attempt has been made to validate the claimed uses of ‘Okra’
Hibiscus esculentus in liver diseases. The preventive action of ethanolic extract of okra (EEO)
against liver injury was evaluated in rodents using carbon tetrachloride-induced hepatotoxicity
model. EEO, at 250 and 500 mg/kg body weight, exerted signiﬁcant dose-dependent hepatoprotec-
tion by decreasing the CCl4-induced elevation of serum SGOT, SGPT, ALP, GGT, cholesterol,
triglycerides and malondialdehyde (MDA) non-protein sulfhydryls (NP-SH) and total protein
(TP) levels in the liver tissue. A signiﬁcant reduction was also observed in pentobarbital-induced
sleeping time in mice. The hepatoprotective and antioxidant activities of the extract are being com-
parable to standard silymarin. These ﬁndings were supported by histological assessment of the liver
biopsy. The ability of okra extract to protect chemically induced liver damage may be attributed to
its potent antioxidant property.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Liver disease is considered to be a serious health problem as
liver is an important organ for the detoxiﬁcation and deposi-
tion of endogenous substances. Administration of vaccines,4677245.
y. Production and hosting by
Saud University.
lseviercorticosteroids and antiviral drugs has been found to be the
best remedial option for the treatment of liver diseases in con-
ventional medicine. These treatments are not free from serious
and adverse effects, especially when given for a prolonged per-
iod (Yang et al., 2008). Therefore, herbs, vegetables and medic-
inal plant products with improved effectiveness and safety
proﬁles are needed as a substitute for chemical drugs. It has
been recognized that vegetables and fruits are essential and
well balanced diet required for a healthy living. It has also been
recognized that high consumption of some vegetables and
fruits are beneﬁcial to health and in combating the onset of
cancer, coronary diseases, inﬂammation, arthritis, immune sys-
tem decline, liver diseases and brain dysfunctions (Shui and
Peng, 2004).
Okra, Hibiscus esculentus L. (Syn. Abelmoschusesculentus)
(EEO) is one of the members of the Malvaceae family. It is
known by many names, Lady’s ﬁnger, Bamyah and Bhindi;
136 S.I. Alqasoumiwhich is eaten raw as well as cooked. Egyptians believed that
eating okra prevents the development of urinary calculi
(Kamal, 1975). In folkloric practice fresh tender pods were
given to cure constipation, leucorrhea, spermatorrhea, diabetes
and jaundice (Chopra et al., 1956). Mucilage is also used as
soothing emollient medicine in the treatment of diarrhea, dys-
entery and gastric ulcer. A cupful of mucilage mixed with a
ripe banana is given as a tonic-food during the treatment of
colitis, cystitis, hepatitis and jaundice (Chopra et al., 1956;
Aman, 1969). A gastroprotective effect of the methanolic
extract of okra in ethanol-induced gastric ulcer in rats was re-
ported (Gurbuz et al., 2003). Recently, some major antioxidant
quercetin derivatives were identiﬁed and isolated from okra
(Shui and Peng, 2004). Fatty and amino acids and minerals,
especially zinc contents (Hirose et al., 2003), and lepidimoide
have been isolated from okra mucilage, which has multiple
functions in the growth and development of plants (Cook et
al., 2000). Based on its folkloric use and reported antioxidant
constituents, the present study was carried out to evaluate the
protective effect of the ethanolic extract of okra (EEO) against
carbon tetrachloride-induced hepatocellular injury in rats.2. Materials and methods
2.1. Drugs and chemicals
Carbon tetrachloride (CCl4) was procured from E. Merck,
Germany. Silymarin was purchased from Sigma Co. (St.
Louis, MO). Enzymatic in vitro diagnostic kits were obtained
from Roche Diagnostics Corporation, UK. All other chemi-
cals used in this study were of analytical grade.
2.2. Plant material and preparation of extract
The fresh pods of ‘Okra’ Hibiscus esculentus were purchased
from the local vegetable market in Riyadh and its identity
was conﬁrmed by expert taxonomist of the Department of
Pharmacognosy, where a voucher specimen (No. 3608) of the
plant has been kept in the Herbarium. Shade dried pods
(500 g) were coarsely powdered and macerated in 3 l of 96%
ethanol for 72 h using percolation method. The solvent was
then removed at 40 C under reduced pressure in a rotavapor.
The extract was then suspended in distilled water before its
administration.
2.3. Phytochemical screening
The preliminary qualitative phytochemical screening of okra
was conducted for the presence and/or absence of alkaloids,
cardiac glycosides, ﬂavonoids, tannins, anthraquinones, sapo-
nins, volatile oils, cyanogenic glycosides, coumarins, sterols
and/or triterpenes (Fransworth, 1966).
2.4. Animals
Wistar albino rats of either sex and approximately the same
age (8–10 weeks), weighing 180–200 g, obtained from the
Experimental Animal Care Centre, College of Pharmacy, King
Saud University, Riyadh, were used. Swiss albino mice were
used for studying sleeping time and acute toxicity. The animals
were kept at a constant temperature (22 ± 2 C), humidity(55%) and 12 h light–dark conditions. The animals were then
provided with Purina chow diet and drinking water ad libitum.
The conduct of experiments and the procedure of sacriﬁce
(using ether) were approved by the Ethics Committee of the
Experimental Animal Care Society, College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.
2.5. Acute toxicity test
The acute toxicity test was performed in ﬁve groups 10 mice
(ﬁve male and ﬁve female mice each). Okra extract was dis-
solved in distilled water and administered orally at various
doses, ranging from 0.5, 1, 2, 4 and 8 g/kg. The animals were
observed for clinical signs and symptoms of toxicity every
30 min up to 6 h on the ﬁrst day and thereafter, everyday up
to 7 days. The mortality occurring in each group was recorded
(Al-Rehaily et al., 2002).
2.6. Carbon tetrachloride-induced liver toxicity
Rats were divided into ﬁve groups (1, 2, 3, 4 and 5) (N= 6 ani-
mals/group). Group 1 was kept as control (distilled water).
Groups 2–5 received CCl4 in liquid parafﬁn (1:1) at 1 ml/kg
body weight intraperitoneally (IP) (Rafatullah et al., 2008).
Group 2 was administered with only CCl4. Groups 3 and 4
were treated with EEO at the doses of 250 and 500 mg/kg body
weight, respectively, and group 5 was administered with silym-
arin at a dose of 10 mg/kg body weight orally. EEO treatment
was started 10 days prior to CCl4 administration and contin-
ued until the end of the experiment. The blood was collected
by cardiac puncture after 24 h following CCl4 administration,
allowed to clot and the serum was separated. After blood col-
lection, the animals were sacriﬁced using ether anesthesia. The
liver was dissected out and used for biochemical studies and
histological examination.
2.7. Estimation of marker enzymes and bilirubin
Serum glutamate oxaloacetate transaminase (SGOT), serum
glutamate pyruvate transaminase (SGPT), alkaline phospha-
tase (ALP), gamma glutamyltransferase (GGT) and bilirubin
were determined using Reﬂotron Plus Analyzer and Roche
kits.
2.8. Estimation of lipid proﬁle
The total cholesterol (Demacher and Hijamaus, 1980) and tri-
glyceride (Foster and Dunn, 1973) levels were estimated in
serum.
2.9. Determination of malondialdehyde (MDA)
The method reported by Utley et al. (1967) was followed. The
liver tissues were removed and each tissue was homogenized in
0.15 M KCl (at 4 C; Potter-Elvehjem type C homogenizer) to
give a 10% w/v homogenate. Aliquots of homogenate (1 ml)
were incubated at 37 C for 3 h in a metabolic shaker. Then
1 ml of 10% aqueous trichloroacetic acid was added and
mixed. The mixture was then centrifuged at 800g for 10 min.
One milliliters of the supernatant was removed and mixed with
1 ml of 0.67% thiobarbituric acid and placed in a boiling water
bath for 10 min. The mixture was cooled and diluted with 1 ml
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at 535 nm. The content of malondialdehyde (nmol/g wet tis-
sue) was then calculated, by reference to a standard curve of
malondialdehyde solution.
2.10. Estimation of non-protein sulfhydryls (NP-SH)
Hepatic non-protein sulfhydryls were measured according to
the method of Sedlak and Lindasy (1968). The liver was
homogenized in ice-cold 0.02 mmol/l ethylenediaminetetraace-
tic acid (EDTA). Aliquots of homogenates (5 ml) were mixed
in test tubes with 4 ml of distilled water and 1 ml of 50% tri-
chloroacetic acid (TCA). The tubes were shaken intermittently
for 10 min and centrifuged at 3000 rpm. Two milliliters of
supernatant mixed with 4 ml of 0.4 mol/l Tris buffer (pH
8.9). 0.1 ml of 5,50-dithio-bis(2-nitrobenzoic acid) (DTNB)
was added and the sample was shaken. The absorbance was
measured within 5 min of the addition of DTNB at 412 nm
against a reagent blank.
2.11. Determination of total protein (TP)
Total protein was estimated by the kit method, supplied by
Crescent Diagnostics, Jeddah, Saudi Arabia.
2.12. Histopathological evaluation
Liver tissue samples were ﬁxed in neutral buffered formalin for
24 h. Sections of the liver tissue were histopathologically exam-
ined to study the hepatoprotective activity of EEO. The tissues
were ﬁxed in 10% buffered formalin and processed using a VIP
tissue processor. The processed tissues were then embedded in
parafﬁn blocks and sections of about 5 lm thickness were cut
by employing an American optical rotary microtome. These
sections were stained with hematoxylin and eosin using routine
procedures (Culling, 1974). The slides were examined micro-
scopically for pathomorphological changes such as congestion,
hemorrhage, edema, and erosions using an arbitrary scale for
severity assessment of these changes.
2.13. Sleeping time
The sleeping time in mice was measured using pentobarbital.
Mice were divided into four groups of 10 animals each. Group
I received the distilled water only; group II received CCl4 only.
Groups III and IV received EEO (250 and 500 mg/kg body
weight). Thirty minutes later, the animals of groups II, III
and IV were treated with pentobarbital (50 mg/kg I.P.). TheTable 1 The effect of EEO on activities of liver marker enzymes in
Groups Treatment Dose
(mg/kg, orally)
SGOT (IU/L
1 Control (distilled water) – 93.71 ± 13.30
2 CCl4
a 334.66 ± 31.9
3 Okra extractb 250 303.66 ± 23.0
4 Okra extractb 500 186.66 ± 19.8
5 Silymarinb 10 132.66 ± 20.5
Data are mean ± SEM. Six rats were used in each group. *P< 0.05, **P
a As compared with control (distilled water) group.
b As compared with CC14 group.time interval between the onset and the regaining of the right-
ing reﬂex was measured as the sleeping time (Dandiya and
Collumbine, 1959).
2.14. Statistical analysis
Values are given as arithmetic means ± standard error of the
mean (SEM). Data were statistically analyzed by using one-
way analysis of variance (ANOVA) followed by the Student’s
t-test.
3. Results
3.1. Phytochemical screening
The preliminary qualitative screening of okra pods, revealed
the presence of ﬂavonoid, tannins, anthracene, sterols and/or
triterpenes.
3.2. Acute toxicity test
No toxicity symptoms were recorded. The LD50 value by oral
route could not be determined as no lethality was observed up
to 8 g/kg of the okra extract in mice.
3.3. Effect of EEO on marker enzymes in serum
The effect of protreatment of rats with ethanolic extract of okra
on the CCl4-induced elevation of the serum GOT, GPT, ALP
and GGT are shown in Table 1. Administration of CCl4 signif-
icantly elevated the release of GOT, GPT, ALP and GGT con-
tents in serum (P< 0.001) as compared to normal control
group. Pretreatment of rats with EEO signiﬁcantly prevented
the elevation of GOT, GPT, ALP and GGT as compared to
CCl4 only treated group. However, the low dose (250 mg/kg)
caused an insigniﬁcant decrease inGOT andGGT levels. Silym-
arin on the other hand, diminished the levels of all marker en-
zymes as compared to the group treated with CCl4 only.
3.4. Effect of EEO on lipid proﬁle and bilirubin in serum
The effect of protreatment of rats with ethanolic extract of
okra on the CCl4-induced elevation of the levels of serum cho-
lesterol, triglycerides and bilirubin are shown in Table 2.
Administration of CCl4 signiﬁcantly elevated the cholesterol,
triglycerides and bilirubin contents in serum (P< 0.001).
Pretreatment of rats with EEO signiﬁcantly prevented the
elevation of cholesterol and triglycerides at both doses used.CC14-induced hepatotoxicity in rats.
) SGPT (IU/L) ALP (IU/L) GGT (IU/L)
23.86 ± 5.87 351.19.93 3.43 ± 0.57
1*** 290.83 ± 28.51*** 878.83 ± 34.49*** 28.51 ± 7.50***
4 197.16 ± 23.01* 686.16 ± 38.22** 17.61 ± 2.79
2** 174.83 ± 20.78** 600.50 ± 4.97*** 9.80 ± 1.27*
1*** 92.65 ± 16.77*** 425.00 ± 27.29*** 7.58 ± 1.81*
< 0.01, ***P< 0.001, Student’s t-test.
Table 2 The effect of EEO on serum cholesterol, triglycerides and bilirubin levels in CCl4-induced hepatotoxicity in rats.
Groups Treatment Dose
(mg/kg, orally)
Cholesterol
(g/dl)
Triglycerides
(g/dl)
Bilirubin
(mg/dl)
1 Control (Distilled water) – 88.48 ± 11.27 72.98 ± 5.07 0.57 ± 0.06
2 CC14
a 134.83 ± 15.76* 149.33 ± 15.06*** 3.30 ± 0.27***
3 Okra extractb 250 69.21 ± 8.63** 83.48 ± 12.38** 2.96 ± 0.15
4 Okra extractb 500 78.98 ± 10.1* 72.04 ± 12.81** 2.77 ± 0.18
5 Silymarinb 10 97.36 ± 16.60 127.16 ± 16.70 1.04 ± 0.16***
Data are mean ± SEM. Six rats were used in each group. *P< 0.05, **P< 0.01, ***P< 0.001, Student’s t-test.
a As compared with control (distilled water) group.
b As compared with CCl4 group.
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Figure 2 Effect of EEO on liver NP-SH concentration in CCl4-
induced hepatic injury. All values represent mean ± -
SEM.*P< 0.05, **P< 0.01, ***P< 0.001; ANOVA, followed
by Dunnett’s multiple comparison test. aAs compared with normal
group. bAs compared with CCl4 only group. n= six rats were
used in each group.
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Figure 3 Effect EEO on liver TP concentration in CCl4-induced
hepatic injury. All values represent mean ± SEM.*P< 0.05,
**P< 0.01, ***P< 0.001; ANOVA, followed by Dunnett’s multi-
ple comparison test. aAs compared with normal group. bAs
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levels. Silymarin could not afford to reduce the cholesterol
and triglyceride levels. On the other hand, silymarin signiﬁ-
cantly diminished the levels of bilirubin as compared to the
CCl4 only treated group.
3.5. Effect of EEO on hepatic MDA
As depicted in Fig. 1, the MDA, an end product of lipid per-
oxidation, in the rats’ liver tissue, treated with CCl4 was in-
creased when compared with the normal control rats.
Pretreatment of rats with EEO resulted in a signiﬁcant and
dose-dependent decrease in the concentration of MDA as com-
pared to the group treated with CCl4 only. Although low dose
(250 mg/kg) of EEO, reduced the MDA level, this decreased le-
vel of MDA was not statistically signiﬁcant. Silymarin treat-
ment signiﬁcantly reduced the MDA concentration as
compared to the group treated with CCl4 only.
3.6. Effect of EEO on Hepatic NP-SH
Fig. 2 showed the reduced levels of NP-SH caused by CCl4
treatment, the EEO at both doses used caused signiﬁcant
and dose-dependent elevation of the NP-SH concentration in
the liver tissue. Silymarin treatment showed a signiﬁcantly en-
hanced NP-SH level as compared to the group treated with
CCl4 only.
3.7. Effect of EEO on hepatic TP
Fig. 3 demonstrated the total protein levels were signiﬁcantly
decreased in CCl4 only treated group. EEO at both doses used0
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Figure 1 Effect of EEO on liver MDA concentration in CCl4-
induced hepatic injury. All values represent mean ± SEM.
*P< 0.05, **P< 0.01, ***P< 0.001; ANOVA, followed by Dun-
nett’s multiple comparison test. aAs compared with normal group.
bAs compared with CCl4 only group. n= six rats were used in each
group.
compared with CCl4 only group. n= six rats were used in each
group.caused signiﬁcant and dose-dependent elevation of the protein
concentration in the liver tissue. Silymarin treated rats also
showed a signiﬁcant increase of total protein as compared to
the group treated with CCl4 only.
3.8. Effect of EER on histopathological evaluation
Histopathological studies provided supportive evidence for the
biochemical analysis. The photomicrographs of the liver
showed severe necrosis and inﬂammation in CCl4 only treated
rats (Fig. 4B) in comparison with normal control (Fig. 4A).
The EEO treated (250 and 500 mg/kg, p.o.) groups showed
minimal inﬂammation (Figs. 4C and 4D). The silymarin trea-
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sence of necrosis (Fig. 4E).
3.9. Effect of EEO on pentobarbital-induced sleeping time
There was a signiﬁcant lowering of pentobarbital-induced
sleeping time following the administration of the EEO in the
CCl4-induced acute liver injury model (Table 3).Figure 4A Liver (normal). Normal hepatocytes. H. & E. 200·.
Figure 4B Liver (treated with CCl4 only). Hepatocytes showed
severe necrosis and inﬂammation. H. & E. 200·.
Figure 4C Liver (treated with CCl4 and 250 mg/kg EEO).
Normal hepatocytes. H. & E. 200·.
Figure 4D Liver (treated with CCl4 and 500 mg/kg EEO).
Normal hepatocytes. H. & E. 200·.
Figure 4E Liver (treated with CCl4 and 10 mg/kg silymarin).
Scattered foci of inﬂammation with the absence of necrosis. H. &
E. 200·.4. Discussion
The damage to the liver after CCl4 administration is a well
known phenomenon, and the obvious sign to hepatic injury
is the leakage of cellular enzymes into the plasma (Recknagel
et al., 1989). The experimental intoxication induced by CCl4
is widely used for modeling liver injuries in rats. Hepatotoxic-
ity is connected with the severe impairment of cell protection
mechanisms. The location of liver injury is deﬁned mainly by
the biotransformation of CCl4, as CCl4 is metabolized by cyto-
chrome P 450 systems to yield trichloromethyl radical (CCL3)
and peroxy radical (CCl3OO
) (Huang et al., 1995), which are
highly reactive oxygen species (ROS) and are capable of com-
bining with membrane lipids and proteins in the presence of O2
to induce lipid peroxidation (LPO) (Kadiiska et al., 2000;
Pradeep et al., 2007). In the present study, the elevated levels
of serum enzymes such as GOT, GPT, ALP and GGT have
been observed in CCl4-treated rats, which indicate the in-
creased permeability, damage, and/or necrosis of the hepatic
cells. The present study demonstrated that orally pre-adminis-
tered EEO suppressed CCl4-induced hepatic injury dramati-
cally. EEO was found to have a hepatoprotective effect, as
shown by its ability to signiﬁcantly reduce CCl4-induced hepa-
tic marker enzymes, cholesterol, triglycerides, and MDA; be-
Table 3 The effect of EEO on duration of pentobarbital sleeping time in mice treated with CCl4.
Groups Treatment Dose Sleeping time
(min)
Reduction
in sleeping
time (%)
1 Pentobarbital only (50 mg/kg, i.p.) 77.50 + 9.26 –
2 Pentobarbital + CCl4
a (50 mg/kg, i.p. + 1.5 ml/kg, i.p.) 165.60 + 9.28*** –
3 EEO+ CCl4 + pentobarbital
b (250 mg/kg, p.o. + 1.5 ml/kg, i.p. + 50 mg/kg, i.p.) 125.80 + 6.84** 24.03
4 EEO+ CCl4 + pentobarbital
b (500 mg/kg, p.o. + 1.5 ml/kg, i.p. + 50 mg/kg, i.p.) 97.20 + 4.57*** 41.30
Data are Mean ± SE. Ten mice were used in each group. **P< 0.01, ***P< 0.001, Student’s t-test.
a As compared with control (distilled water) group.
b As compared with CC14 group.
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hyperlipidemic effect of EEO may be due to the down regula-
tion of NADPH and NADH cofactors in the fat metabolism.
EEO may also exert its antilipidemic action by oxidizing
NADPH (Fernandes et al., 2007; Al-Dosari et al., 2011).
The elevated level of MDA, which is one of the end prod-
ucts of lipid peroxidation in the liver tissue and diminished lev-
els of total protein and NP-SH are important indicators of
tissue damage and failure of antioxidant defense mechanisms
to prevent the formation of excessive free radicals in CCl4-
intoxicated animals (Souza et al., 1997). In this study, it was
observed that the CCl4-induced depletion of NP-SH and TP
were replenished signiﬁcantly and the increased MDA levels
were suppressed (compared with the CCl4 only treated group).
The EEO pretreatment successfully quenched the free radicals
thereby inhibiting lipid peroxidation and protecting the mem-
brane lipids from oxidative damage in the liver of rats
(Pradeep et al., 2007). Hence, EEO acts as a potent antioxida-
tive agent under in vivo conditions (Arapitsas, 2008) and an
earlier report also highlighted the in vitro antioxidative effect
of okra water extract (Ansari et al., 2005). The treatment of
rats with CCl4 caused damage to microsomal drug metaboliz-
ing enzymes in hepatocytes leading to a substantial decrease in
hepatic drug metabolizing capacity, being reﬂected in the pro-
longation of pentobarbital-induced sleeping time (Rafatullah
et al., 1991; Janbaz et al., 2004). The pretreatment of mice with
EEO prevented the CCl4-induced prolongation in pentobarbi-
tal-induced narcolepsy, further conﬁrming a protective effect
of EEO against CCl4-induced damage to hepatocytes.
The preliminary phytochemical studies showed that ﬂavo-
noids, tannins, sterols and triterpenes were present in okra.
Phytoconstituents, such as ﬂavonoids are commonly present
in vegetables and fruits, which provide the health-beneﬁts,
associated with diets rich in plant-food. Flavonoids are a class
of secondary plant phenolics, found ubiquitously in fruits, veg-
etables and medicinal plants (Al-Howiriny et al., 2003;
Yazdanparast et al., 2008) which are known to play a pivotal
role as dietary antioxidants for the prevention of oxidative
damage in the living system (Hertog et al., 1993). Furthermore,
a large number of biological actions of ﬂavonoids have been
attributed to their potent antioxidant properties; as they act
in different ways, including direct quenching ROS, chelation
of metal ions and regeneration of membrane-bound antioxi-
dants (Heber, 2004; Sunilson et al., 2008). The obtained results
demonstrated that the possible mechanisms of okra extract to
protect liver toxicity produced by CCl4 in rats, might be due to
following effects: (i) prevention of lipid peroxidation; (ii) the
hepatocyte membrane stabilization; (iii) abolishment or inhibi-tion of the cytochrome P 450-dependent oxygenase activity
and (iv) enhancement of non-protein sulfhydryls (NP-SH)
and total proteins (TP) concentration in liver tissue possibly
due to its antioxidative potential. However, from the data ob-
tained it is concluded that the active phytoconstituents of
Hibiscus esculentus pods, which are responsible for the ob-
tained liver-protective and antioxidant effects, have been only
detected but not isolated in this study and support the claims
made by Hakims and Vaids for its usefulness in liver and gas-
tro-intestinal ailments.Acknowledgements
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